• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺动脉高压中的血液动力学:当前和未来的观点。

Hemodynamics in pulmonary arterial hypertension: current and future perspectives.

机构信息

Medical Intensive Care Unit, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.

出版信息

Am J Cardiol. 2012 Sep 15;110(6 Suppl):9S-15S. doi: 10.1016/j.amjcard.2012.06.011.

DOI:10.1016/j.amjcard.2012.06.011
PMID:22921033
Abstract

Right heart catheterization (RHC)-determined pulmonary hemodynamics are mandatory for the diagnosis and classification of pulmonary hypertension (PH) and can be used to assess response to PH-specific therapy and inform clinical decision-making. PH is diagnosed in patients with a mean pulmonary arterial pressure of ≥25 mm Hg at rest, with a further classification of pulmonary arterial hypertension (PAH) in patients with a pulmonary artery wedge pressure of ≤15 mm Hg and, often, reduced cardiac output. In addition, a number of hemodynamic variables, either measured directly with RHC or subsequently derived, have been shown to have prognostic significance in PAH, with different variables having more prognostic significance in specific patient populations. Although there is no hemodynamic definition of exercise-induced PAH, measurement of certain hemodynamic variables during exercise may identify an intermediary phenotype between healthy individuals and overt PAH at rest and may have prognostic implications. However, although exercise hemodynamics may be a closer reflection of the true resistive component of the pulmonary vasculature and its ability to respond to therapy, the lack of standardized protocols limits application in routine clinical practice.

摘要

右心导管检查(RHC)确定的肺血流动力学对于肺动脉高压(PH)的诊断和分类是必需的,可用于评估对 PH 特异性治疗的反应并为临床决策提供信息。PH 被诊断为静息时平均肺动脉压≥25mmHg,在肺动脉楔压≤15mmHg 且通常心输出量降低的患者中进一步分类为肺动脉高压(PAH)。此外,已经证明 RHC 直接测量或随后推导的许多血流动力学变量在 PAH 中具有预后意义,不同的变量在特定患者群体中具有更重要的预后意义。虽然运动性 PAH 没有血流动力学定义,但在运动过程中测量某些血流动力学变量可能会在健康个体和静息时明显 PAH 之间识别出一种中间表型,并且可能具有预后意义。然而,尽管运动血流动力学可能更接近肺血管的真实阻力成分及其对治疗的反应能力,但缺乏标准化方案限制了其在常规临床实践中的应用。

相似文献

1
Hemodynamics in pulmonary arterial hypertension: current and future perspectives.肺动脉高压中的血液动力学:当前和未来的观点。
Am J Cardiol. 2012 Sep 15;110(6 Suppl):9S-15S. doi: 10.1016/j.amjcard.2012.06.011.
2
Definition, classification, and epidemiology of pulmonary arterial hypertension.肺动脉高压的定义、分类及流行病学
Semin Respir Crit Care Med. 2009 Aug;30(4):369-75. doi: 10.1055/s-0029-1233306. Epub 2009 Jul 24.
3
[Resting and exercise hemodynamics in pulmonary arterial hypertension].[肺动脉高压中的静息和运动血流动力学]
Presse Med. 2011 Apr;40 Suppl 1:1S28-38. doi: 10.1016/S0755-4982(11)70005-7.
4
[Dana Point: what is new in the diagnosis of pulmonary hypertension?].[达纳角:肺动脉高压诊断有哪些新进展?]
Dtsch Med Wochenschr. 2008 Oct;133 Suppl 6:S180-2. doi: 10.1055/s-0028-1091233. Epub 2008 Sep 23.
5
Diagnostics in pulmonary hypertension.肺动脉高压的诊断
J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):591-602.
6
Definitions and diagnosis of pulmonary hypertension.肺动脉高压的定义和诊断。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D42-50. doi: 10.1016/j.jacc.2013.10.032.
7
[Investigation of pulmonary hypertension].[肺动脉高压的研究]
Rev Pneumol Clin. 2008 Jun;64(3):151-61. doi: 10.1016/j.pneumo.2008.05.001. Epub 2008 Jul 7.
8
Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension.目前用于确定肺毛细血管楔压的方法容易导致肺动脉高压患者分类出现严重错误。
Am Heart J. 2012 Apr;163(4):589-94. doi: 10.1016/j.ahj.2012.01.024.
9
Pulmonary arterial hypertension: evaluation of the newly diagnosed patient.肺动脉高压:新诊断患者的评估
Semin Respir Crit Care Med. 2005 Aug;26(4):372-8. doi: 10.1055/s-2005-916151.
10
Diagnosis and differential assessment of pulmonary arterial hypertension.肺动脉高压的诊断与鉴别评估
J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):40S-47S. doi: 10.1016/j.jacc.2004.02.032.

引用本文的文献

1
Right heart catheterization in clinical practice: a review of basic physiology and important issues relevant to interpretation.临床实践中的右心导管检查:基础生理学及解读相关重要问题综述
Am J Cardiovasc Dis. 2023 Jun 25;13(3):122-137. eCollection 2023.
2
Outcomes and Prognostic Factors of Pulmonary Hypertension Patients Undergoing Emergent Endotracheal Intubation.急诊行气管插管的肺动脉高压患者的结局和预后因素。
J Intensive Care Med. 2023 Mar;38(3):280-289. doi: 10.1177/08850666221118839. Epub 2022 Aug 8.
3
Exercise-Induced Pulmonary Hypertension Is Associated with High Cardiovascular Risk in Patients with HIV.
运动诱发性肺动脉高压与HIV患者的高心血管风险相关。
J Clin Med. 2022 Apr 27;11(9):2447. doi: 10.3390/jcm11092447.
4
Ventilatory efficiency in pulmonary vascular diseases.肺血管疾病中的通气效率。
Eur Respir Rev. 2021 Jul 20;30(161). doi: 10.1183/16000617.0214-2020. Print 2021 Sep 30.
5
Patient-Specific Computational Analysis of Hemodynamics and Wall Mechanics and Their Interactions in Pulmonary Arterial Hypertension.肺动脉高压中血流动力学和血管壁力学及其相互作用的患者特异性计算分析
Front Bioeng Biotechnol. 2021 Jan 28;8:611149. doi: 10.3389/fbioe.2020.611149. eCollection 2020.
6
Acute vasoreactivity testing predicts outcome of idiopathic pulmonary arterial hypertension patients with a negative acute response.急性血管反应性测试可预测特发性肺动脉高压患者急性反应阴性时的预后。
Ann Transl Med. 2020 Dec;8(24):1650. doi: 10.21037/atm-20-7339.
7
Pulmonary Vascular Disease and Cardiopulmonary Exercise Testing.肺血管疾病与心肺运动试验
Front Physiol. 2020 Aug 5;11:964. doi: 10.3389/fphys.2020.00964. eCollection 2020.
8
Radiological and hemodynamic parameters in patients with suspected ventricular aneurysm and interventricular septal perforation after acute myocardial infarction: A comparison of non-invasive and invasive diagnostic modalities.急性心肌梗死后疑似室壁瘤和室间隔穿孔患者的放射学和血流动力学参数:无创与有创诊断方式的比较
Exp Ther Med. 2020 Aug;20(2):961-967. doi: 10.3892/etm.2020.8754. Epub 2020 May 15.
9
The Role of Biomarkers and Surrogate End Points in Drug Development for Neonatal Pulmonary Arterial Hypertension.生物标志物和替代终点在新生儿肺动脉高压药物研发中的作用
Neoreviews. 2016 Feb 1;17(2):e87-e92. doi: 10.1542/neo.17-2-e87.
10
Design of the exercise MRI evaluation of HIV-pulmonary arterial hypertension longitudinal determinants (EXALTED) trial.EXALTED 试验:运动 MRI 评估 HIV 肺动脉高压纵向决定因素的设计。
J Cardiovasc Med (Hagerstown). 2017 Nov;18(11):888-896. doi: 10.2459/JCM.0000000000000575.